Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma
about
Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma
description
im August 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 03 August 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2019
@uk
name
Pre-clinical evaluation of sec ...... oblastic leukemia and lymphoma
@en
Pre-clinical evaluation of sec ...... oblastic leukemia and lymphoma
@nl
type
label
Pre-clinical evaluation of sec ...... oblastic leukemia and lymphoma
@en
Pre-clinical evaluation of sec ...... oblastic leukemia and lymphoma
@nl
prefLabel
Pre-clinical evaluation of sec ...... oblastic leukemia and lymphoma
@en
Pre-clinical evaluation of sec ...... oblastic leukemia and lymphoma
@nl
P2093
P50
P1433
P1476
Pre-clinical evaluation of sec ...... oblastic leukemia and lymphoma
@en
P2093
Anne Uyttebroeck
Aurore Touzart
Barbara De Moerloose
Beatrice Lintermans
Benedetta Accordi
Birgit Burkhardt
Dieter Deforce
Elizabeth Macintyre
Federica Lovisa
Filip Matthijssens
P304
P356
10.3324/HAEMATOL.2018.199257
P407
P577
2018-08-03T00:00:00Z